Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+
Clinical trial NCT02936089 · COMPLETED
Trial details
- NCT number
- NCT02936089
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2021-12-31
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.